Neuropsychiatry

Tonmya, a groundbreaking fibromyalgia treatment, is now available in the US, offering hope for millions suffering from chronic pain.

Today is World Stroke Day. Understanding what lies ahead in the road to stroke recovery can help patients and their families prepare for the challenges they will face.

Discover how advanced diagnostic tools enhance the accuracy of dementia assessments, leading to better treatment strategies and patient outcomes.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.

Explore the complex neuropsychiatric symptoms of Huntington disease and the challenges in treatment and management for affected patients.

Researchers unveil a groundbreaking nasal spray using lithium-loaded gold nanoparticles, targeting brain diseases with reduced adverse effects.

Reproductive psychiatrist Sarah Oreck, MD, MS challenges the FDA's claims linking acetaminophen use in pregnancy to autism and ADHD, advocating for informed maternal care.

Bristol Myers Squibb's BMS-986446 receives FDA Fast Track Designation, aiming to transform early Alzheimer disease treatment by targeting tau pathology.

Late-life depression poses unique challenges, impacting cognitive function and requiring tailored treatment strategies for older adults.

In this CME article, explore the complexities of movement disorders in psychiatric practice, including their causes, symptoms, and treatment strategies for better patient care.

Apathy significantly affects cognitive impairment patients, yet remains underrecognized. Discover effective assessment and treatment strategies for improved outcomes.

Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.

Because stuttering represents a spectrum disorder, a spectrum of treatments are needed.

Shelly Jo Kraft, MS, PhD, lays the foundation for a new approach that emphasizes the role of comorbidities in stuttering.

Shahriar SheikhBahaei, PhD, discusses how animal models may lead to better treatments.

Collaborating with speech pathologists and others improve care for patients who stutter.

Shahriar SheikhBahaei, PhD, shares insights into the neurobiology of stuttering at STARS conference.

Gerald A. Maguire, MD, details the unmet needs in stuttering at the inaugural conference.

Alto Neuroscience reveals EEG biomarkers effectively distinguish patients with schizophrenia, enhancing treatment precision and advancing psychiatric research.

Neuroplasticity enables the brain to adapt and recover after injury, emphasizing the importance of multidisciplinary rehabilitation for effective healing.

Explore the complex interplay of genetics, environment, concussion, substance abuse, and inflammation in severe mental illnesses, revealing critical insights for prevention and treatment.

Leqembi for the treatment of Alzheimer disease has been launched in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025—the first launches in the EU.

New research highlights lithium's crucial role in brain health, revealing its potential to combat Alzheimer disease and enhance mental wellness.

Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.